Global Leader in Animal Health

Our Ambition is to Improve Animal Health Today and in the Future

monitor

Monitor

We will leverage new technologies and science in order to monitor in real time and detect disease earlier

diagnose

Diagnose

We will develop novel tools that supports targeted therapy in livestock

prevent

Prevent

Together we can provide tailored and comprehensive programs to safeguard animal health today and in the future

Business Segments

World Leader Across Species

Organised in two strategic business units, Boehringer Ingelheim Animal Health delivers a large and innovative portfolio of products and services to prevent disease and improve the health and productivity of animals around the world.

parasiticides

Global Leader in Parasiticides #4 global market position

vet-public-health

Veterinary Public Health #1 global market position

“We are passionate about animal health and recognise the critical importance of serving animal health needs globally, with a special focus on prevention. We know that when animals are healthy, humans are healthier, too.”

Joachim Hasenmaier
Member of the Boehringer Ingelheim Board of Managing Directors

Key Facts + Figures

about-global

Present in

Over 150 Countries
Worldwide

about-employees

More than

10,000 Animal Health
Employees Worldwide

about-headquaters

Global Headquarters in

Ingelheim
Germany

about-parasiticides

A Global

Leader in
Parasiticides

Global Operations Footprint

An extensive manufacturing network close to and serving markets needs

global-operations-footprint-dt
global-operations-footprint-mob

Global R&D Footprint

Strong R&D Centers connected to key growth areas of Europe, North America & Asia

global-rd-footprint-dt
global-rd-footprint-mob

Our Responsibility

A focused and comprehensive Corporate Responsibility approach, aligned with our strategy and addressing our most pressing sustainability challenges: disease emergence, protein demand, stronger links with pets and environmental degradation.

LINK

Create a healthy and mutually beneficial human-animal bond

SECURE

Expand access to responsible animal healthcare to promote food security

PRESERVE

Care for the planet and take effective steps to minimize our environmental footprint

History

1885

A family-owned company with 28 employees, headquartered in Ingelheim, Germany was founded by Albert Boehringer.

1897

Merieux founded the Institut Biologique Mérieux (Mérieux Biological Institute), in Lyon, France. This early vaccine research and production center was the starting point for the animal health endeavors that would one day become the company Merial.

1955

Boehringer Ingelheim’s Animal Health division was established as the company takes over Pfizer’s veterinary program.

1997

Merial was created through the merger of Rhône Mérieux (Rhône-Poulenc, France) and MSD AgVet (Merck & Co, US)

2009

Merial becomes a wholly-owned subsidiary of Sanofi.

2015

Boehringer Ingelheim enters into exclusive negotiations with Sanofi consisting of a strategic exchange of their consumer healthcare business for Merial.

2017

Two complementary companies, Boehringer Ingelheim and Merial, unite through a passion for animals and a joint history of integrity, quality and trust.